Research Compounds

Semaglutide

A long-acting GLP-1 receptor agonist widely studied for its effects on glucose homeostasis and energy regulation.

Tirzepatide

A dual GIP/GLP-1 receptor co-agonist offering a unique dual-incretin mechanism studied for superior metabolic modulation.

Retatrutide

A triple GIP/GLP-1/glucagon receptor agonist representing the cutting edge of multi-incretin metabolic research.

BPC-157

A cytoprotective pentadecapeptide derived from gastric juice protein, extensively studied for its tissue-repair signalling properties.

TB-500 (Thymosin Beta-4)

A synthetic analogue of the ubiquitous actin-sequestering protein Thymosin Beta-4, studied for its roles in cellular migration and repair.

GHK-Cu

A naturally occurring copper-binding tripeptide with broad gene-regulatory effects studied in the context of tissue remodelling and cellular health.

Epithalon

A synthetic tetrapeptide derived from the pineal gland epithalamin, studied for its telomerase-activating and circadian-regulatory properties.

MOTS-c

A mitochondria-derived peptide encoded in the 12S rRNA gene, studied as a novel regulator of metabolic flexibility and cellular stress response.

CJC-1295 + Ipamorelin

A synergistic GHRH/GHRP combination studied for producing robust, pulsatile growth hormone release with favourable selectivity profiles.

Tesamorelin

A stabilised GHRH(1-44) analogue with a trans-3-hexenoic acid modification, studied for its selective stimulation of pituitary GH secretion.